DRIO logo

DarioHealth (DRIO) EBITDA

Annual EBITDA

-$54.38 M
+$1.22 M+2.19%

December 31, 2023

Summary

Performance

1-Year Change

+2.19%

3-Year Change

-83.01%

5-Year Change

-211.07%

15-Year Change

-282.3%

DRIO EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

31.31%
DRIO annual EBITDA is higher than 31.31% of companies in Healthcare sector

High & Low

All-time High

-$3.95 M

3-Year Low

-$72.27 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
DRIO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 28, 2025
DRIO next annual earnings announcement is scheduled for Mar 28, 2025

OtherDRIOprofitabilitymetrics:

Annual Revenue

$20.35 M
DRIO annual revenue is $20.35 million

Annual Net Income

-$59.43 M
DRIO annual net profit is -$59.43 million

Annual EBIT

-$59.36 M
DRIO annual earnings before interest & taxes is -$59.36 million

Annual EPS

-$1.93
DRIO annual earnings per share is -$1.93

Quarterly EBITDA

-$9.90 M
+$4.45 M+31.01%

September 30, 2024

Summary

Performance

3-Month Change

+31.01%

1-Year Change

+30.8%

3-Year Change

+50.87%

5-Year Change

-259.55%

DRIO Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

35.99%
DRIO quarterly EBITDA is higher than 35.99% of companies in Healthcare sector

High & Low

All-time High

-$493.20 K

3-Year Low

-$20.68 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
DRIO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
DRIO next earnings announcement is scheduled for Mar 28, 2025

OtherDRIOprofitabilitymetrics:

Quarterly Revenue

$7.42 M
DRIO quarterly revenue is $7.42 million

Quarterly Net Income

-$12.33 M
DRIO quarterly net profit is -$12.33 million

Quarterly EBIT

-$12.03 M
DRIO quarterly earnings before interest & taxes is -$12.03 million

Quarterly EPS

-$0.25
DRIO quarterly earnings per share is -$0.25

TTM EBITDA

-$56.85 M
+$4.41 M+7.20%

September 30, 2024

Summary

Performance

3-Month Change

+7.2%

1-Year Change

-14.69%

3-Year Change

+5.65%

5-Year Change

-224.47%

DRIO TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

29.7%
DRIO TTM EBITDA is higher than 29.7% of companies in Healthcare sector

High & Low

All-time High

-$493.20 K

3-Year Low

-$72.92 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
DRIO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
DRIO next earnings announcement is scheduled for Mar 28, 2025

OtherDRIOprofitabilitymetrics:

TTM Revenue

$23.05 M
DRIO TTM revenue is $23.05 million

TTM Net Income

-$47.40 M
DRIO TTM net profit is -$47.40 million

TTM EBIT

-$63.47 M
DRIO TTM earnings before interest & taxes is -$63.47 million

TTM EPS

-$0.94
DRIO TTM earnings per share is -$0.94

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$54.38 M
DRIO annual EBITDA is -$54.38 million

Annual Net Income

-$59.43 M
DRIO annual net profit is -$59.43 million

Annual Interest Expense

$0.00
DRIO annual interest expense is $0.00

Annual Income Tax

$64.00 K
DRIO annual income tax is $64.00 thousand

Annual D&A

$4.99 M
DRIO annual depreciation & amortization is $4.99 million

DRIO EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+2.2%+30.8%-14.7%
3 y3 years-83.0%+50.9%+5.7%
5 y5 years-211.1%-259.6%-224.5%

DRIO EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+24.8%at high+52.1%-17.0%+22.0%
5 y5-year-210.3%+24.8%-142.9%+52.1%-224.5%+22.0%
alltimeall time-1276.6%+24.8%-1907.7%+52.1%<-9999.0%+22.0%

DarioHealth EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$9.90 M(-31.0%)
-$56.85 M(-7.2%)
Jun 2024
-
-$14.35 M(-13.2%)
-$61.26 M(+2.6%)
Mar 2024
-
-$16.53 M(+2.9%)
-$59.71 M(+9.8%)
Dec 2023
-$54.38 M(-2.2%)
-$16.07 M(+12.3%)
-$54.38 M(+9.7%)
Sep 2023
-
-$14.31 M(+11.8%)
-$49.57 M(+2.0%)
Jun 2023
-
-$12.80 M(+14.3%)
-$48.61 M(-6.4%)
Mar 2023
-
-$11.20 M(-0.6%)
-$51.95 M(-6.6%)
Dec 2022
-$55.60 M(-23.1%)
-$11.26 M(-15.6%)
-$55.64 M(-14.5%)
Sep 2022
-
-$13.35 M(-17.3%)
-$65.06 M(-9.5%)
Jun 2022
-
-$16.15 M(+8.5%)
-$71.86 M(-1.4%)
Mar 2022
-
-$14.88 M(-28.0%)
-$72.92 M(+1.4%)
Dec 2021
-$72.27 M(+143.2%)
-$20.68 M(+2.6%)
-$71.93 M(+19.4%)
Sep 2021
-
-$20.16 M(+17.2%)
-$60.26 M(+29.1%)
Jun 2021
-
-$17.20 M(+23.9%)
-$46.66 M(+39.1%)
Mar 2021
-
-$13.89 M(+54.1%)
-$33.53 M(+12.9%)
Dec 2020
-$29.71 M(+69.6%)
-$9.01 M(+37.5%)
-$29.71 M(+19.6%)
Sep 2020
-
-$6.55 M(+60.8%)
-$24.84 M(+18.1%)
Jun 2020
-
-$4.08 M(-59.5%)
-$21.04 M(-5.6%)
Mar 2020
-
-$10.07 M(+143.4%)
-$22.27 M(+27.1%)
Dec 2019
-$17.52 M(+0.2%)
-$4.14 M(+50.2%)
-$17.52 M(-4.1%)
Sep 2019
-
-$2.75 M(-48.2%)
-$18.27 M(-6.4%)
Jun 2019
-
-$5.32 M(-0.0%)
-$19.51 M(-2.2%)
Mar 2019
-
-$5.32 M(+9.0%)
-$19.94 M(+14.0%)
Dec 2018
-$17.48 M
-$4.88 M(+22.1%)
-$17.48 M(+11.5%)
Sep 2018
-
-$4.00 M(-30.5%)
-$15.68 M(+7.3%)
DateAnnualQuarterlyTTM
Jun 2018
-
-$5.75 M(+100.7%)
-$14.61 M(+13.0%)
Mar 2018
-
-$2.86 M(-7.0%)
-$12.92 M(-9.1%)
Dec 2017
-$14.22 M(+36.2%)
-$3.08 M(+5.2%)
-$14.22 M(-2.6%)
Sep 2017
-
-$2.92 M(-28.0%)
-$14.60 M(+2.0%)
Jun 2017
-
-$4.06 M(-2.5%)
-$14.31 M(+11.9%)
Mar 2017
-
-$4.16 M(+20.6%)
-$12.79 M(+22.4%)
Dec 2016
-$10.45 M(+41.9%)
-$3.45 M(+30.8%)
-$10.45 M(+19.1%)
Sep 2016
-
-$2.64 M(+4.1%)
-$8.77 M(+2.1%)
Jun 2016
-
-$2.53 M(+39.2%)
-$8.59 M(+14.8%)
Mar 2016
-
-$1.82 M(+2.6%)
-$7.49 M(+1.7%)
Dec 2015
-$7.36 M(-28.7%)
-$1.77 M(-27.9%)
-$7.36 M(-3.0%)
Sep 2015
-
-$2.46 M(+72.4%)
-$7.59 M(+0.8%)
Jun 2015
-
-$1.43 M(-15.9%)
-$7.53 M(-21.1%)
Mar 2015
-
-$1.70 M(-15.2%)
-$9.55 M(-7.5%)
Dec 2014
-$10.32 M(-18.9%)
-$2.00 M(-16.7%)
-$10.32 M(-11.9%)
Sep 2014
-
-$2.40 M(-30.2%)
-$11.71 M(-1.9%)
Jun 2014
-
-$3.44 M(+39.4%)
-$11.94 M(+0.4%)
Mar 2014
-
-$2.47 M(-27.2%)
-$11.90 M(-3.9%)
Dec 2013
-$12.72 M(+222.1%)
-$3.39 M(+28.7%)
-$12.38 M(+17.2%)
Sep 2013
-
-$2.64 M(-22.5%)
-$10.57 M(+18.0%)
Jun 2013
-
-$3.40 M(+14.9%)
-$8.95 M(+39.5%)
Mar 2013
-
-$2.96 M(+88.2%)
-$6.42 M(+62.4%)
Dec 2012
-$3.95 M
-$1.57 M(+54.2%)
-$3.95 M(+66.1%)
Sep 2012
-
-$1.02 M(+18.0%)
-$2.38 M(+75.2%)
Jun 2012
-
-$864.20 K(+75.2%)
-$1.36 M(+175.2%)
Mar 2012
-
-$493.20 K
-$493.20 K

FAQ

  • What is DarioHealth annual EBITDA?
  • What is the all time high annual EBITDA for DarioHealth?
  • What is DarioHealth annual EBITDA year-on-year change?
  • What is DarioHealth quarterly EBITDA?
  • What is the all time high quarterly EBITDA for DarioHealth?
  • What is DarioHealth quarterly EBITDA year-on-year change?
  • What is DarioHealth TTM EBITDA?
  • What is the all time high TTM EBITDA for DarioHealth?
  • What is DarioHealth TTM EBITDA year-on-year change?

What is DarioHealth annual EBITDA?

The current annual EBITDA of DRIO is -$54.38 M

What is the all time high annual EBITDA for DarioHealth?

DarioHealth all-time high annual EBITDA is -$3.95 M

What is DarioHealth annual EBITDA year-on-year change?

Over the past year, DRIO annual EBITDA has changed by +$1.22 M (+2.19%)

What is DarioHealth quarterly EBITDA?

The current quarterly EBITDA of DRIO is -$9.90 M

What is the all time high quarterly EBITDA for DarioHealth?

DarioHealth all-time high quarterly EBITDA is -$493.20 K

What is DarioHealth quarterly EBITDA year-on-year change?

Over the past year, DRIO quarterly EBITDA has changed by +$4.41 M (+30.80%)

What is DarioHealth TTM EBITDA?

The current TTM EBITDA of DRIO is -$56.85 M

What is the all time high TTM EBITDA for DarioHealth?

DarioHealth all-time high TTM EBITDA is -$493.20 K

What is DarioHealth TTM EBITDA year-on-year change?

Over the past year, DRIO TTM EBITDA has changed by -$7.28 M (-14.69%)